Ignite Creation Date:
2024-05-05 @ 10:03 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01013220
Status:
COMPLETED
Last Update Posted:
2014-12-16
First Post:
2009-11-12
Brief Title:
Depression Management at the Workplace
Sponsor:
Florida State University
Organization:
Florida State University
Study Overview
Official Title:
Influencing Employer Purchasing Behavior
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DMW
Brief Summary:
Randomized trials demonstrate that depression management products can improve clinical and organizational outcomes sufficiently for selected employers to realize a return on investment Rather than usual care marketing which uses voltage-enhanced promises to sell voltage-diminished products the investigators designed an evidence-based EB intervention to encourage employers to purchase a depression management product that offers the type intensity and duration of care shown to provide clinical and organizational value In an RCT designed to examine employer benefit purchasing behavior of depression products in 360 employer members of over 20 regional business coalitions the research team proposes a to compare the impact of evidence-based EB to usual care UC presentations on employer benefit purchasing behavior and b to identify mediators and organizational moderators of intervention impact on employer benefit purchasing behavior
This study addresses what policy analysts argue is one of the most pivotal problems in the translation of evidence-based care to real world settings whether purchasers can be influenced to buy health care products on the basis of value rather than cost In the likely event that EB UC the study will provide encouragement to use an evidence-based approach to market new health care products to private payers on the basis of the products clinical and organizational value UC may achieve comparable outcomes to EB if the limiting factors in benefit purchasing are organizational purchasing group and vendor constraints that no intervention can meaningfully modify Support for this scenario would encourage the targeted marketing of new products to coalition members with empirically identified organizational purchasing group and vendor characteristics using usual care strategies
This study addresses what policy analysts argue is one of the most pivotal problems in the translation of evidence-based care to real world settings whether purchasers can be influenced to buy health care products on the basis of value rather than cost In the likely event that EB UC the study will provide encouragement to use an evidence-based approach to market new health care products to private payers on the basis of the products clinical and organizational value UC may achieve comparable outcomes to EB if the limiting factors in benefit purchasing are organizational purchasing group and vendor constraints that no intervention can meaningfully modify Support for this scenario would encourage the targeted marketing of new products to coalition members with empirically identified organizational purchasing group and vendor characteristics using usual care strategies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None